Friday, May 19, 2023 9:53:00 AM
Todos at the top of the list
Future of 3CL Protease Inhibitor Market 2023: Active Key Players and Emerging Trends in Industry till 2030 - Published: May 18, 2023
https://www.marketwatch.com/press-release/future-of-3cl-protease-inhibitor-market-2023-active-key-players-and-emerging-trends-in-industry-till-2030-2023-05-18
LOOOOOKKKKKK >>>>>>>>
- Todos Medical
- Pfizer
- Shionogi
- Enanta Pharmaceuticals
- Cocrystal Pharma
- Insilico Medicine
- Everest Medicines
- Raynovent
- Simcere
- Cosunter
- Ascletis Pharma
- Frontier Biotechnologies
Recent TOMDF News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/17/2023 12:29:32 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM